AKYA

NASDAQ

Akoya BioSciences Inc.

SectorIndustrialsIndustryBiotechnology: Laboratory Analytical InstrumentsIPO2021

News25/Ratings12

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Latest news

25 items

279dSEC
SEC Form 15-12G filed by Akoya BioSciences Inc.
15-12G - Akoya Biosciences, Inc. (0001711933) (Filer)
284dSEC
SEC Form EFFECT filed by Akoya BioSciences Inc.
EFFECT - Akoya Biosciences, Inc. (0001711933) (Filer)
287dINSIDER
Director Mendel Scott disposed of 28,500 shares, closing all direct ownership in the company (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
Chief Business Officer Ramachandran Niro Ph.D acquired 62,566 shares, covered exercise/tax liability with 42,148 shares and disposed of 282,555 shares, closing all direct ownership in the company (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
President and CEO Mckelligon Brian disposed of 947,688 shares, acquired 724,428 shares and covered exercise/tax liability with 196,866 shares, closing all direct ownership in the company (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
Chief Legal Officer Kamocsay Jennifer disposed of 179,272 shares, closing all direct ownership in the company (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
CFO Ek John Frederick disposed of 268,202 shares, closing all direct ownership in the company (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
Chief Clinical Officer Bamford Pascal disposed of 205,738 shares, closing all direct ownership in the company (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
Director Winkler Matthew disposed of 984,513 shares, closing all direct ownership in the company (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
SEC Form 4 filed by Director Shepler Robert G
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
SEC Form 4 filed by Director Schnettler Thomas P
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
Director Raffin Thomas A. disposed of 17,909,839 shares (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
287dINSIDER
Director Lai Goldman Myla disposed of 20,000 shares, closing all direct ownership in the company (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)
289dSEC
SEC Form S-8 POS filed by Akoya BioSciences Inc.
S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
289dSEC
SEC Form S-8 POS filed by Akoya BioSciences Inc.
S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
289dSEC
SEC Form S-8 POS filed by Akoya BioSciences Inc.
S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
289dSEC
SEC Form S-8 POS filed by Akoya BioSciences Inc.
S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
289dSEC
SEC Form S-8 POS filed by Akoya BioSciences Inc.
S-8 POS - Akoya Biosciences, Inc. (0001711933) (Filer)
289dSEC
SEC Form POS AM filed by Akoya BioSciences Inc.
POS AM - Akoya Biosciences, Inc. (0001711933) (Filer)
289dSEC
SEC Form 25-NSE filed by Akoya BioSciences Inc.
25-NSE - Akoya Biosciences, Inc. (0001711933) (Subject)
289dSEC
Akoya BioSciences Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits
8-K - Akoya Biosciences, Inc. (0001711933) (Filer)
290dSEC
Akoya BioSciences Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - Akoya Biosciences, Inc. (0001711933) (Filer)
311dSEC
SEC Form DEFM14A filed by Akoya BioSciences Inc.
DEFM14A - Akoya Biosciences, Inc. (0001711933) (Filer)
323dSEC
SEC Form 425 filed by Akoya BioSciences Inc.
425 - Akoya Biosciences, Inc. (0001711933) (Subject)
325dINSIDER
Chief Clinical Officer Bamford Pascal covered exercise/tax liability with 670 shares, decreasing direct ownership by 0.32% to 205,738 units (SEC Form 4)
4 - Akoya Biosciences, Inc. (0001711933) (Issuer)